| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/05/2008 | US7326720 Phenyl- and pyridylpiperidines with TNF activity |
| 02/05/2008 | US7326719 Cathepsin S inhibitors |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326684 Peptides for enhancing resistance to microbial infections |
| 02/05/2008 | US7326681 Methods for producing modified glycoproteins |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2390746C Quinolinone derivative pharmaceutical composition and production method therefor |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/05/2008 | CA2255867C Chitosan induced immunopotentiation |
| 02/05/2008 | CA2165039C Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
| 01/31/2008 | WO2008014222A1 Crystalline forms of rapamycin analogs |
| 01/31/2008 | WO2008014186A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 01/31/2008 | WO2008013082A1 Galectin 9-polymer conjugate |
| 01/31/2008 | WO2008012645A2 Use of vitamin d3 agonist in a mammalian model for atopic diseases and of vitamin d3 antagonists for the treatment of atopic diseases |
| 01/31/2008 | WO2008012563A2 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 01/31/2008 | WO2008012338A2 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
| 01/31/2008 | WO2008012326A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | WO2008012031A2 Blockers of gsk3 for the prevention and treatment of pemphigus vulgaris |
| 01/31/2008 | WO2008011884A1 Novel immunomodulator |
| 01/31/2008 | WO2008011726A1 Staged immune-response modulation in oncolytic therapy |
| 01/31/2008 | WO2007143382A3 Oral liquid loratadine formulations and methods |
| 01/31/2008 | WO2007139833A3 Imidazoazephinone compounds |
| 01/31/2008 | WO2007098507A3 Compositions and methods for inhibition of the jak pathway |
| 01/31/2008 | WO2006134190A8 Agents and methods based on the use of the eda domain of fibronectin |
| 01/31/2008 | US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes |
| 01/31/2008 | US20080027213 Chimeric immunogens |
| 01/31/2008 | US20080027133 Use of chromen-4-one derivatives |
| 01/31/2008 | US20080027126 Pyrrolidin-2-One Derivatives for Use as Dp1 Receptor Agonists |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080026998 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 01/31/2008 | US20080026995 Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 01/31/2008 | US20080026075 Constitutional Function-Improving Agents |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080026007 Potentiation of the immune response |
| 01/31/2008 | US20080026001 Pharmaceutical composition from natural materials for regulating immunity, its preparation method and use |
| 01/31/2008 | US20080025998 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chilamydia |
| 01/31/2008 | US20080025997 Cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 01/31/2008 | US20080025985 Method of treating a pathological syndrome and a pharmaceutical agent |
| 01/31/2008 | US20080025980 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject; HIV infection or AIDS (Acquired Immune Deficiency Syndrome) |
| 01/31/2008 | US20080025979 Programmed Death 1(PD-1); bispecific antibodies comprising antibodies against human T cell receptor complex or human B cell receptor complex; autoimmune diseases |
| 01/31/2008 | US20080025974 Toll-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation and viral infection |
| 01/31/2008 | US20080025971 Antibody comprising a human heavy chain framework sequence, three heavy chain hypervariable region sequences and three light chain hypervariable region sequences; modulating biological activity of integrins containing the beta7 subunit |
| 01/31/2008 | US20080025968 Methods and Agents for Immune Modulation and Methods for Identifying Immune Modulators |
| 01/31/2008 | US20080025951 Administering to an individual having acute liver disease or inflammatory skin disease a carrier and a specific polypeptide that contains signal peptide sequences and a transmembrane spanning domain |
| 01/31/2008 | US20080025947 Methods for enhancing the efficacy of IL-2 mediated immune responses |
| 01/31/2008 | US20080025944 Combination Therapy for Immunostimulation |
| 01/31/2008 | DE102006033837A1 Konzentrierte Methotrexat-Lösungen Concentrated methotrexate solutions |
| 01/31/2008 | CA2659055A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 01/31/2008 | CA2658951A1 Adult sertoli cells and uses thereof |
| 01/31/2008 | CA2658896A1 Crystalline forms of rapamycin analogs |
| 01/31/2008 | CA2658584A1 Staged immune-response modulation in oncolytic therapy |
| 01/31/2008 | CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/30/2008 | EP1882695A2 Pharmaceutically active compounds and methods of use thereof |
| 01/30/2008 | EP1881846A2 Compositions for antigen-specific induction of immuno-tolerance via oral immunization |
| 01/30/2008 | CN101115772A Cytotoxic antibody directed against type-B lymphoid haematopoietic prolifeeations |
| 01/30/2008 | CN101115761A Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 01/30/2008 | CN101115742A Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 01/30/2008 | CN101115504A Minor allergen control to increase safety of immunotherapy |
| 01/30/2008 | CN101112614A Glair NRBP having important functions in regulating and controlling in immunoregulation |
| 01/30/2008 | CN101112535A Medicinal composition and food and drink extender for improving immunity |
| 01/30/2008 | CN101112448A Donkey-hide gelatin composition having immunity improving effect and method of making the same |
| 01/30/2008 | CN101112402A Medicinal composition and food and drink extender for improving immunity |
| 01/30/2008 | CN101112397A Viable prebiotics bacteria microcapsule preparations for livestock and method for preparing the same |
| 01/30/2008 | CN101112390A Joint production method for distilling immunopotentiator from waste blood |
| 01/30/2008 | CN101112280A Traditional Chinese medicine health care pillow |
| 01/30/2008 | CN100365119C Polypeptide of anti HIV virus and its coding gene and application |
| 01/30/2008 | CN100365022C Fusion toxin protein and uses thereof |
| 01/30/2008 | CN100365007C New type trisaccharide and penta saccharid oligo saccharide antigen, their synthesis method and application in preparation of medicine for inhibiting exclusion reaction |
| 01/30/2008 | CN100364939C Chinese medicine effective-part extract for treating hypersensitive diseases and extraction process |
| 01/30/2008 | CN100364611C Peptide immunotherapeutic agent |
| 01/30/2008 | CN100364544C Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/30/2008 | CN100364538C Application of fugillin in treating immunity entiritis and related immunity disease |
| 01/30/2008 | CN100364527C Composition of vitamin C and arginine and its application |
| 01/30/2008 | CN100364434C Health-caring tea of sweet wormwood and its preparation |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323471 Administering azathioprine, 6-mercaptopurine, or 6-thioguanine nucleotide, or their salts for treating graft-versus-host disease of the mouth; oral rinse |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 01/29/2008 | US7323442 Due to bacteria infections; administering lactoferrin |
| 01/29/2008 | US7323440 De-immunized MOG (poly)peptide constructs |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323311 Methods of obtaining a specific binding member that binds eotaxin |
| 01/29/2008 | US7323183 Vaccine compositions including chitosan for intranasal administration and use thereof |
| 01/29/2008 | US7323177 delivery vectors for antigen producing genes (heterologous gene sequences or fragments thereof) used to generate immune responses in commercial pigs; recombinant porcine adenovirus capable of expressing DNA of interest |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | US7323170 Anti-CD80 antibodies |
| 01/29/2008 | CA2417455C Novel cyclooxygenase variants and methods of use |
| 01/29/2008 | CA2312885C 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |